Literature DB >> 16987158

EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias.

A May1, M Leone, J Afra, M Linde, P S Sándor, S Evers, P J Goadsby.   

Abstract

Cluster headache and the other trigeminal-autonomic cephalalgias [paroxysmal hemicrania, short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) syndrome] are rare but very disabling conditions with a major impact on the patient's quality of life. The objective of this study was to give evidence-based recommendations for the treatment of these headache disorders based on a literature search and consensus amongst a panel of experts. All available medical reference systems were screened for any kind of studies on cluster headache, paroxysmal hemicrania and SUNCT syndrome. The findings in these studies were evaluated according to the recommendations of the European Federation of Neurological Societies resulting in level A, B or C recommendations and good practice points. For the acute treatment of cluster headache attacks, oxygen (100%) with a flow of at least 7 l/min over 15 min and 6 mg subcutaneous sumatriptan are drugs of first choice. Prophylaxis of cluster headache should be performed with verapamil at a daily dose of at least 240 mg (maximum dose depends on efficacy or tolerability). Although no class I or II trials are available, steroids are clearly effective in cluster headache. Therefore, the use of at least 100 mg methylprednisone (or equivalent corticosteroid) given orally or at up to 500 mg i.v. per day over 5 days (then tapering down) is recommended. Methysergide, lithium and topiramate are recommended as alternative treatments. Surgical procedures, although in part promising, require further scientific evaluation. For paroxysmal hemicranias, indomethacin at a daily dose of up to 225 mg is the drug of choice. For treatment of SUNCT syndrome, large series suggest that lamotrigine is the most effective preventive agent, with topiramate and gabapentin also being useful. Intravenous lidocaine may also be helpful as an acute therapy when patients are extremely distressed and disabled by frequent attacks.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16987158     DOI: 10.1111/j.1468-1331.2006.01566.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  93 in total

Review 1.  [Facial and eye pain - Neurological differential diagnosis].

Authors:  O Kastrup; H-C Diener; C Gaul
Journal:  Ophthalmologe       Date:  2011-12       Impact factor: 1.059

2.  High-flow oxygen: a gladly received fresh look at an old but effective abortive treatment for cluster headache.

Authors:  Ivan Garza
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

3.  Clinical features of unilateral headaches beyond migraine and cluster headache and their response to indomethacin.

Authors:  Stefan Seidel; Doris Lieba-Samal; Marion Vigl; Christian Wöber
Journal:  Wien Klin Wochenschr       Date:  2011-07-26       Impact factor: 1.704

Review 4.  Guideline for primary care management of headache in adults.

Authors:  Werner J Becker; Ted Findlay; Carmen Moga; N Ann Scott; Christa Harstall; Paul Taenzer
Journal:  Can Fam Physician       Date:  2015-08       Impact factor: 3.275

5.  Improved surgical procedure using intraoperative navigation for the implantation of the SPG microstimulator in patients with chronic cluster headache.

Authors:  Carsten Kohlmeier; Peter Behrens; Andreas Böger; Brinda Ramachandran; Anthony Caparso; Dirk Schulze; Philipp Stude; Max Heiland; Alexandre T Assaf
Journal:  Int J Comput Assist Radiol Surg       Date:  2017-01-12       Impact factor: 2.924

6.  A retrospective observation on 105 patients with chronic cluster headache receiving indomethacin.

Authors:  Anaé Monta; Sylvain Redon; Cyprien Fabre; Anne Donnet
Journal:  Neurol Sci       Date:  2021-02-05       Impact factor: 3.307

7.  Inhaled Oxygen for Cluster Headache: Efficacy, Mechanism of Action, Utilization, and Economics.

Authors:  Todd D Rozen
Journal:  Curr Pain Headache Rep       Date:  2012-01-29

Review 8.  Sphenopalatine Ganglion Block in the Management of Chronic Headaches.

Authors:  Jeffrey Mojica; Bi Mo; Andrew Ng
Journal:  Curr Pain Headache Rep       Date:  2017-06

Review 9.  Mechanism of action of indomethacin in indomethacin-responsive headaches.

Authors:  Oliver Summ; Stefan Evers
Journal:  Curr Pain Headache Rep       Date:  2013-04

10.  SUNCT and SUNA: Recognition and Treatment.

Authors:  Juan A Pareja; Mónica Alvarez; Teresa Montojo
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.